Ledger.Open graph →

SEC Form D · filed January 21, 2015

Adaptive Biotechnologies Corp

Offering

$95.7M

Sold

$95.7M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SEATTLE, WA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (29)

Dean Schorno · SEATTLE, WAExec Lee Huntsman · SEATTLE, WADirector Kathleen Determann · SEATTLE, WAExec Andris Zoltners · SEATTLE, WADirector Chad Robins · SEATTLE, WAExec · Director John Stuelpnagel · SEATTLE, WADirector Peter Neupert · SEATTLE, WADirector Arnold Levine · SEATTLE, WADirector Rob Rosen · SEATTLE, WADirector Rob Hershberg · SEATTLE, WADirector Tom Willis · SEATTLE, WADirector Dennis Moon · Atlanta, GAExec Leonard Dipietra · New York, NYExec Jeffery Wright · Atlanta, GADirector Justin Mahoney · Stamford, CTDirector Joshua D. Rand · New York, NYExec · Director Paul A. Mahon · Winnipeg, Manitoba, CanadaDirector Nicole Rothschild · New York, NYDirector Samer Atiani · Rego Park, NYDirector Scott Haufe · Atlanta, GADirector James Andrews · Atlanta, GAExec · Director Patrick Kullman · Atlanta, GAExec · Director Jarrett Gorlin · Atlanta, GADirector John Thomas, Jr · Atlanta, GADirector C.A. Hennies · Atlanta, GAExec · Director Larry Papasan · Atlanta, GADirector Gregory D. Tretiak · Winnipeg, Manitoba, CanadaDirector Siim A. Vanaselja · Winnipeg, Manitoba, CanadaDirector Andrew D. Brands · Winnipeg, Manitoba, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗